MedPath

Towards patient-led follow-up after curative treatment of stage II and III colorectal cancer

Conditions
<p>Colorectal cancer</p>
Registration Number
NL-OMON20781
Lead Sponsor
/A
Brief Summary

/A

Detailed Description

Not available

Recruitment & Eligibility

Status
Pending
Sex
Not specified
Target Recruitment
360
Inclusion Criteria

- Patient has pT2-4N0M0 or pT1-4N1-2M0 primary colorectal carcinoma treated with surgical resection with curative intent; - Patient is aged = 18 years; - Patient is willing to participate in the Prospective Dutch CRC cohort (PLCRC); - Patient is disease-free at 12 months after resection (assessed by CT thorax19 abdomen, CEA and colonoscopy).

Exclusion Criteria

- Patient has macroscopically (R2) incomplete resections; - Patient needs in-hospital follow-up longer than 12 months postoperatively (e.g. patients with a severely complicated postoperative course, or patients enrolled in other studies that require in-hospital follow-up consultations); - Patient has confirmed hereditary CRC

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>Primary endpoint is the proportion of participant who have contacted the hospital between 12 and 24 months after curative surgery.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Secondary endpoints are quality of life, fear of cancer recurrence, patient satisfaction, cost-effectiveness and survival.</p><br>
© Copyright 2025. All Rights Reserved by MedPath